Name Levodopa
Classes Central Nervous System Agent
Anti-Parkinson Agent
Dopamine Agonist / Dopaminergic Agent
Diseases CNS Disorder
Parkinson's Disease

Levodopa

Levodopa is a dopaminergic agent that is converted to dopamine in the brain. It is used to treat the symptoms of Parkinson's disease.

 

Levodopa is indicated for the treatment of Parkinson's disease and its associated symptoms, including tremors, rigidity, and bradykinesia.

 

  • Levodopa is usually available in combination with carbidopa.
  • The dosage and administration of levodopa depend on the patient's age, weight, and the severity of the disease. It is usually administered orally, with or without food. The recommended initial dose is 100 mg three times daily, with gradual increases up to a maximum of 2000 mg per day.

 

 

Side effects associated with Levodopa include-

  • choreiform
  • dystonic
  • involuntary movements
  • nausea
  • chest pain
  • hallucination
  • paranoia
  • asthenia
  • hypotension
  • phlebitis
  • hypertension
  • agranulocytosis

 

  • Levodopa should be used with caution in patients with a history of cardiovascular disease, hypertension, or arrhythmias.
  • Patients with a history of psychosis or depression should be monitored closely during levodopa administration, as it may exacerbate these conditions.
  • Levodopa may interact with other medications, including antipsychotics, antidepressants, and antihypertensive agents, leading to adverse effects.
  • Patients taking levodopa should avoid high-protein foods, as they may reduce the drug's effectiveness.
  • Levodopa should not be used during pregnancy, as it may harm the developing fetus.

Contraindication

  • Levodopa is contraindicated in patients with known hypersensitivity to any component of this drug.
  • Concomitant administration with non selective monoamine oxidase (MAO) inhibitors are contraindicated.
    • Phenelzine
    • Isocarboxazid
    • Tranylcypromine

 

Contraindicated in patients with suspicious, undiagnosed skin lesions or a history of melanoma.